Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Inferiority Study Comparing Treatment of Primary Knee Osteoarthritis With Intra-Articular Triamcinolone Injections Using 40mg With Landmark Guidance and 20mg With Ultrasound Guidance: The PRECISION-Knee Trial (PRospective Evaluation of the Clinical Impact of Steroid Injection Options iN Knee Osteoarthritis)

NCT07544576 is registered in ClinicalTrials.gov with Sosi Dzhugarian as lead sponsor.

NCT NCT07544576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07544576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Inferiority Study Comparing Treatment of Primary Knee Osteoarthritis With Intra-Articular Triamcinolone Injections Using 40mg With Landmark Guidance and 20mg With Ultrasound Guidance: The PRECISION-Knee Trial (PRospective Evaluation of the Clinical Impact of Steroid Injection Options iN Knee Osteoarthritis)
Lead sponsor
Sosi Dzhugarian
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
December 12, 2025
Completion date
December 8, 2026
Enrollment
140 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

knee arthritis osteoarthritis